ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
25.50
-0.72 (-2.75%)
Jul 13, 2026, 4:00 PM EDT - Market closed
ACADIA Pharmaceuticals Employees
As of December 31, 2025, ACADIA Pharmaceuticals had 798 total employees, including 796 full-time and 2 part-time employees. The number of employees increased by 144 or 22.02% compared to the previous year.
Employees
798
Change (1Y)
144
Growth (1Y)
22.02%
Revenue / Employee
$1,372,494
Profits / Employee
$470,739
Market Cap
4.37B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Caris Life Sciences | 1,846 |
| Denali Therapeutics | 507 |
| Dyne Therapeutics | 263 |
| Relay Therapeutics | 193 |
| Catalyst Pharmaceuticals | 182 |
| Edgewise Therapeutics | 154 |
| Tango Therapeutics | 137 |
ACAD News
- 6 days ago - Acadia Pharmaceuticals price target raised to $36 from $29 at RBC Capital - TheFly
- 7 days ago - Acadia Pharmaceuticals appoints Carl Segerstorm as CPO - TheFly
- 7 days ago - Acadia Pharmaceuticals Appoints Carl Segerstrom as Chief People Officer - Business Wire
- 13 days ago - Acadia Pharmaceuticals price target raised to $30 from $29 at BofA - TheFly
- 14 days ago - Acadia Pharmaceuticals price target raised to $37 from $32 at Deutsche Bank - TheFly
- 14 days ago - Acadia Pharmaceuticals price target raised to $36 from $32 at Canaccord - TheFly
- 15 days ago - Citi adds ‘upside 90-day catalyst watch’ on Acadia Pharmaceuticals - TheFly
- 15 days ago - Acadia Pharmaceuticals price target raised to $35 from $32 at Citi - TheFly